PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PDF +
Supplementary
Material

Colon

Original research

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Online download statistics by month:

Online download statistics by month: January 2021 to July 2022

	Abstract	Full	Pdf
Jan 2021	988	881	425
Feb 2021	647	558	278
Mar 2021	483	448	213
Apr 2021	283	264	155
May 2021	240	233	119
Jun 2021	192	184	104
Jul 2021	148	148	72
Aug 2021	151	148	88
Sep 2021	124	123	92
Oct 2021	172	172	100
Nov 2021	207	205	105
Dec 2021	695	686	246
Jan 2022	458	417	209
Feb 2022	237	214	147
Mar 2022	244	236	171
Apr 2022	241	214	162
May 2022	241	216	166
Jun 2022	177	159	106
Jul 2022	118	124	97
Total	6046	5630	3055